Strategizing Drug Therapies in Pulmonary Hypertension for Improved Outcomes
Pulmonary hypertension (PH) is characterized by a resting mean pulmonary artery pressure (PAP) of 20 mmHg or more and is a disease of multiple etiologies. Of the various types of PH, pulmonary arterial hypertension (PAH) is characterized by elevated resistance in the pulmonary arterial tree. It is a...
Saved in:
Main Authors: | Taylor Beckmann (Author), Patrisha Shelley (Author), Darshan Patel (Author), Mounica Vorla (Author), Dinesh K. Kalra (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Meta-Analysis of the Safety and Efficacy of Direct Oral Anticoagulants for the Treatment of Left Ventricular Thrombus
by: Mounica Vorla, et al.
Published: (2024) -
Pulmonary Agenesis and Associated Pulmonary Hypertension: A Case Report and Review on Variability, Therapy, and Outcome
by: Oliver Muensterer, et al.
Published: (2015) -
Strategic Learning Techniques - Measures Enhancing the Visibility of the Cognitive Process of Learning
by: Helen Beckmann-Hamzei
Published: (2017) -
Drug-induced pulmonary artery hypertension
by: O. D. Ostroumova, et al.
Published: (2022) -
Oxygen-Sensitivity and Pulmonary Selectivity of Vasodilators as Potential Drugs for Pulmonary Hypertension
by: Daniel Morales-Cano, et al.
Published: (2021)